Related Experiment Videos
5-hydroxytryptophan and pyridoxine. Their effects in young children with Down's syndrome
Insights
This study on Down's syndrome children found that 5-hydroxytryptophan and pyridoxine equally improved 5-hydroxyindole levels in 40%. Cognitive development showed differences, particularly in children with highly compliant parents.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Biochemistry
Background:
- Down syndrome is a genetic disorder associated with developmental delays.
- Investigating biochemical and developmental interventions is crucial for improving outcomes in children with Down syndrome.
Purpose of the Study:
- To evaluate the effects of 5-hydroxytryptophan (5-HTP) and pyridoxine hydrochloride on 5-hydroxyindole blood levels in infants with Down syndrome.
- To assess the impact of these supplements on muscle tone and cognitive-adaptive function in early childhood.
Main Methods:
- A double-blind study involving 89 children with Down syndrome.
- Administration of 5-hydroxytryptophan or pyridoxine hydrochloride during the first three years of life.
- Analysis of 5-hydroxyindole blood levels, muscle-tone ratings, and cognitive-adaptive function using the Vineland Social Maturity Scale.
Main Results:
- Both 5-hydroxytryptophan and pyridoxine, individually or combined, equally increased 5-hydroxyindole blood levels in 40% of participants.
- No significant differences in muscle tone were observed after excluding children with congenital heart disease.
- Significant differences in cognitive-adaptive function were noted on the Vineland Social Maturity Scale, linked to parental compliance with guidance, where higher compliance correlated with better outcomes.
Conclusions:
- 5-hydroxytryptophan and pyridoxine show potential in modulating 5-hydroxyindole levels in a subset of children with Down syndrome.
- Early supplementation does not appear to significantly impact muscle tone in this population.
- Parental engagement and adherence to guidance play a significant role in the cognitive development of children with Down syndrome.
Abstract:
In a double-blind study, 89 children with Down's syndrome were given 5-hydroxytryptophan or pyridoxine hydrochloride in the first three years of life. The analysis of 5-hydroxyindole blood levels revealed that 5-hydroxytryptophan, pyridoxine, and the combination of 5-hydroxytryptophan and pyridoxine raised blood levels of 5-hydroxyindole equally well in 40% of the children. The assessment of muscle-tone ratings showed no significant difference among the study groups once children with moderate and severe congenital heart disease were excluded. Detailed studies of cognitive-adaptive function of children in the various groups found a significant difference ont the Vineland Social Maturity Scale at ages 6, 12, 18, and 36 months; yet the source of significance was a negative interaction affecting children whose parents were able to comply with furnished guidance; these children showed consistently higher levels of accomplishment.